Orbit Pharma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 1.00 M
as on 19-12-2024
- Company Age 4 Months 1 Day
- Open Charges ₹ 12.29 Cr
as on 19-12-2024
- Satisfied Charges ₹ 1.23 Cr
as on 19-12-2024
About Orbit Pharma Laboratories
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹12.29 Cr. The company has closed loans amounting to ₹1.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Orbit Pharma Laboratories Limited India is Hiteshbhai Chaudhari as COMPANY SECRETARY. Naranbhai Kikani, Smitaben Kikani, Kunal Kikani, and Four other members serve as directors at the Company.
- CIN/LLPIN
U32503GJ2024PLC154551
- Company No.
154551
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Orbit Pharma Laboratories?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kunal Kikani | Managing Director | 21-Aug-2024 | Current |
Hiteshbhai Chaudhari | Company Secretary | 08-Nov-2024 | Current |
Board Members(6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Naranbhai Kikani | Director | 21-Aug-2024 | Current |
Smitaben Kikani | Director | 21-Aug-2024 | Current |
Sumitkumar Patel | Director | 07-Oct-2024 | Current |
Premaram Patel | Director | 07-Oct-2024 | Current |
Ankitkumar Agrawal | Director | 07-Oct-2024 | Current |
Kunal Yagnik | Director | 07-Oct-2024 | Current |
Financial Performance and Corporate Structure Insights of Orbit Pharma Laboratories.
Enhance accessibility to Orbit Pharma Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Orbit Pharma Laboratories?
Unlock access to Orbit Pharma Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Fabtech Projects And Engineers LimitedActive 22 years 6 months
Ankitkumar Agrawal is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hero Fincorp Limited Creation Date: 29 Mar 2024 | ₹1.68 Cr | Open |
Bank Of Maharashtra Creation Date: 28 Jan 2022 | ₹2.11 Cr | Open |
Bank Of Maharashtra Creation Date: 26 Oct 2020 | ₹1.00 Cr | Open |
How Many Employees Work at Orbit Pharma Laboratories?
Unlock and access historical data on people associated with Orbit Pharma Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orbit Pharma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbit Pharma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.